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e have previously shown that prostatic stem
cells are located in the proximal region of
mouse prostatic ducts. Here, we show that
this region responds differently to transforming growth
factor (TGF)- than the distal ductal region and that under
physiological conditions androgens and TGF- are crucial overall regulators of prostatic tissue homeostasis. This
conclusion is supported by the observations showing that
high levels of TGF- signaling are present in the quiescent
proximal region of ducts in an androgen-replete animal
and that cells in this region overexpress Bcl-2, which protects them from apoptosis. Moreover, androgen ablation

reverses the proximal-distal TGF- signaling gradient,
leading to an increase in TGF- signaling in the unprotected distal region (low Bcl-2 expression). This reversal
of TGF-–mediated signaling accompanies apoptosis of
cells in the distal region and gland involution after androgen withdrawal. A physiological TGF- signaling gradient (high proximally and low distally) and its functional
correlates are restored after androgen replenishment. In
addition to highlighting the regulatory role of androgens
and TGF-, these findings may have important implications for the deregulation of the stem cell compartment in
the etiology of proliferative prostatic diseases.

Introduction
The prostate is an androgen-dependent organ and is the site of
two significant diseases, namely prostate carcinoma and benign
prostatic hyperplasia (BPH), the etiologies of which are poorly
understood. The presence of a population of long-lived stem
cells that survives androgen ablation in the prostate is indicated
by the fact that the prostate regenerates normally after more
than 30 cycles of involution-regeneration (Isaacs, 1985). As tumor cells may originate within the stem cell population (Reya
et al., 2001; Pardal et al., 2003; Beachy et al., 2004; Valk-Lingbeek et al., 2004), the identification of prostate stem cells and
an understanding of their biology is important for elucidating
the mechanisms by which cancer and other proliferative diseases of the prostate arise.
Stem cells are generally quiescent and reside in a specialized cellular location known as a niche. The niche provides a
microenvironment that maintains the balance between quiescence and self-renewal of the stem cell population. The mechanism by which the niche maintains the primitive phenotype of
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cells is poorly understood. Significant evidence indicates that
stem cell homeostasis in some systems is regulated by a balance between the inhibitory effects of TGF- and the stimulatory effects of mitogenic cytokines, indicating that a balance of
stimulatory and inhibitory signals is likely to regulate stem cell
quiescence and proliferation (Cashman et al., 1992; Gabrilove
et al., 1994; Fortunel et al., 2000b). TGF- has also been
shown to inhibit the proliferation of primitive cells of several
origins (Puolakkainen et al., 1994; Potten et al., 1995, 1997;
Gorska et al., 1998; Fan et al., 2002). Recently, it has been
shown that epidermal label-retaining cells in the hair follicle
bulge region (stem cell niche) have an increased expression of
latent TGF- binding protein (LTBP-1), which is necessary for
TGF- activation, and phosphorylated SMAD (pSMAD), which
is implicated in TGF- signaling (Fuchs et al., 2004; Tumbar et
al., 2004), indicating that TGF- activation and signaling may
be important in this stem cell niche.
The mouse prostate can be divided into ventral, dorsal,
and lateral lobes with each lobe consisting of a branched ductal
network that opens into the urethra. Each duct consists of a
proximal region (adjacent to the urethra), an intermediate region, and a distal region (Fig. 1). We recently demonstrated that
the proximal region of murine prostatic ducts contains a population of cells exhibiting features of stem cells, namely slow-
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Figure 1. Microdissected prostatic ducts. A segment from a microdissected mouse dorsal prostate showing the distal, intermediate, and proximal
regions of prostatic ducts. Bar, 1 mm.

cycling cells with high proliferative potential capable of reconstituting branched glandular ductal structures from a single cell
(Tsujimura et al., 2002). We propose that the stem cell population in the proximal region of the prostate is kept in a quiescent
state in its niche by a balance between TGF-, which inhibits
proliferation of the stem cells, and other mitogenic cytokines
that promote proliferation. In this paper, we show that cells in
the proximal and distal regions of prostatic ducts respond differentially to TGF-. In the intact prostate, active TGF- in the
proximal region maintains the stem cells in a quiescent state.
During castration-induced involution, TGF- signaling increases distally. The increased signaling distally results in the
apoptosis of cells in this region, leading to involution of the
prostate. At the same time, TGF- signaling decreases proximally, thus “priming” stem cells in this region to respond to mitogenic growth factors. With androgen replacement, the reduced
levels of TGF- signaling in the proximal region, in conjunction
with expression of various stimulatory cytokines, facilitates division of the stem cells. Once the prostate has regenerated,
TGF- signaling in the proximal region increases and is again
significantly higher than that of the distal region, thereby maintaining quiescence of the stem cells in the proximal region. Our
data indicate that Bcl-2 levels are significantly higher in cells in
the proximal compared with the remaining regions, thus insuring that these cells are protected from apoptosis after androgen
withdrawal and are therefore available to regenerate the gland
after subsequent androgen addition.

Results
Proximal cells produce and activate more
TGF-  than distal cells

As we propose that stem cells in the proximal region are maintained in a quiescent state by TGF-, we examined different
ductal regions immunohistochemically to determine if regional
differences in TGF- levels were evident. We found that TGF-
is produced by both epithelial and stromal cells in all ductal regions (unpublished data). As TGF- is secreted as a biologically inactive latent complex that is activated extracellularly
(Massague et al., 1991; Abe et al., 1994; Munger et al., 1997)
and as commercial antibodies that detect its histological presence do not distinguish between latent and active TGF-, we
82
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Figure 2. Proximal cells produce and activate more TGF- than distal
cells. (A) Heat-activated conditioned medium from proximal and distal
cells (4  104 cells/24-well dish) was placed on TGF-–responsive mink
lung cells. The amount of total TGF- was quantified by comparison with a
standard curve. (B) Active TGF- was measured directly by quantifying
luciferase activity using a coculture assay in which either proximal or distal
cells (4  103 cells/well) were combined with TGF-–responsive mink
lung cells (5  103 cells/well) in a 96-well plate. The presence of TGF- in
A and B was verified using TGF-–neutralizing antibodies.

isolated cells from proximal and distal regions and determined
the levels of total (latent plus active) and active TGF- produced by the cells of different ductal regions in vitro. Both
proximal and distal cells produced latent TGF-, with proximal
cells producing more of the cytokine than distal cells (61.0 
3.1 and 52.8  2.9 pg TGF-/103 cells, respectively; P  0.01;
Fig. 2 A). In addition, a significantly larger fraction of the latent TGF- was activated by proximal cells (19.7  3.5 pg
TGF- /103 cells; 32.3% of the latent TGF-) than by distal
cells (2.3  1.2 pg TGF- /103 cells; 4.3% of the latent TGF-;
P  0.001; Fig. 2 B). Thus, proximal cells both produce and
activate significantly more TGF- than do distal cells, suggesting that the quiescence of stem cells in the proximal prostate is
maintained by autocrine synthesis and activation of TGF-.
As the growth of the prostate is regulated by androgens,
changes in androgen status are likely to modulate stem cell homeostasis. We next determined whether androgen removal and
replacement affect levels of TGF- signaling in vivo. TGF-1–
mediated activation of TGF- receptors induces phosphorylation of SMADs 2 and 3, which then form complexes with
SMAD 4 (Massague et al., 1991; Munger et al., 1997). This
complex translocates to the nucleus where it modulates the expression of TGF-–regulated target genes (Massague et al.,
1991; Munger et al., 1997). Therefore, the presence of nuclear
pSMAD 2 and 3 (pSMAD2/3) was used as an indication of
TGF- receptor activation in vivo. Prostates were removed
from intact androgen-replete mice and at 1, 3, 8, and 14 d after
castration. After 14 d of involution, some mice were given androgen in the form of a subcutaneous androgen pellet and prostates were removed 1, 3, 8, and 14 d later.

Immunohistochemistry was used to detect the presence
of pSMAD2/3 in prostate tissue sections. In the intact androgenreplete prostate (Fig. 3, T0), pSMAD2/3 was present mainly in
the proximal region of the prostatic ducts, with little expression in the distal region (62.3  6.8% positive nuclei in the
proximal region compared with 15.5  1.6% in the distal region; P  0.001; Fig. 3, A, B, and G). However, 1 d after castration, pSMAD2/3 expression increased markedly in the distal region of the ducts (from 15.5  1.6 to 38.9  4.5%
positive nuclei; P  0.01), but remained similar in the proximal region (from 62.3  6.8 to 61.3  5.3% positive nuclei;
Fig. 3, C, D, and G). By 8 d after castration, pSMAD2/3 was
lower proximally than distally (43.9  1.9 vs. 65.4  7.1%
positive nuclei, respectively; P  0.01; Fig. 3, E–G). The
number of pSMAD-expressing cells did not change significantly between 8 and 14 d after castration (unpublished data).
When androgens were replaced by means of a slow-release
subcutaneous androgen pellet (Tsujimura et al., 2002), the levels of pSMAD2/3 returned to the levels detected in the intact
prostate within 8 d (65.3  2.8% positive nuclei proximally
and 17.1  5.5% distally; P  0.001; Fig. 3 G). A similar pattern of results was obtained when the expression of pSMAD
was verified by Western blotting using extracts of prostates
and antibodies to this protein (unpublished data).
The incidence of pSMAD expression in basal and luminal cells was also determined as basal and luminal cells have
both been shown to form prostatic tissue (Kurita et al., 2004)
and as luminal cells are more sensitive to androgen withdrawal than basal cells (English et al., 1987; Evans and
Chandler, 1987). In the proximal region of the intact androgen-replete prostate (Fig. 3, T0) more TGF- signaling
was noted in luminal (72.3  2.8% more than in basal cells
[52.3  1.3%; P 0.01]) whereas similar numbers of luminal (17.1  0.5%) and basal (13.9  0.8%) cells had active
TGF- signaling in the distal region (Fig. 3 H). In contrast,
by 8 d after castration, pSMAD expression in distal luminal
cells (90.7  1.3%) was significantly greater than in distal
basal cells (40.0  2.7%; P  0.001), whereas approximately equal numbers of proximal basal (42.0  2.5%) and
luminal (45.8  2.7%) cells had TGF- signaling at this
time. These data show that TGF- signaling is more pronounced in luminal than basal cells in the distal region,
which may account for the greater apoptosis of this compartment after androgen withdrawal.
These data also indicate that proximal cells produce and
activate more TGF- than distal cells in vitro and that TGF-
signaling is modulated by androgens in vivo. In the intact
prostate, TGF- production and pSMAD signaling is greater
in the stem cell–containing proximal region than in the distal
region. After castration, the amount of pSMAD signaling decreases in the proximal region, but increases dramatically in
the distal region. With androgen replacement, the opposite is
observed, with pSMAD signaling decreasing distally but increasing again proximally. These results indicate that the high
level of TGF- signaling in the proximal region in vivo in androgen-replete animals is likely to maintain the quiescence of
cells in this region.

Figure 3. pSMAD 2 and 3 expression are differentially regulated by
androgens in proximal and distal cells. (A–F) Paraffin sections of the
proximal (A, C, and E) and distal (B, D, and F) regions of ducts examined immunohistochemically for pSMAD2/3-expressing cells in tissues removed from androgen-replete animals (A and B), and after androgen
deprivation for 1 d (D1, no androgen; C and D) and 8 d (D8, no androgen; E and F). Bars, 100 m. (G) Quantification of the number of nuclei
positive for pSMAD2/3 expression in proximal and distal cells in the intact prostate (T0), the prostate 1 (D1-A), 3 (D3-A), and 8 d (D8-A) after
castration and after 1 (D1A), 3 (D3A), and 8 d (D8A) of androgen
administration to animals with involuted prostates. (H) Quantification of
the number of basal and luminal nuclei positive for pSMAD2/3 expression in proximal and distal cells in the intact prostate (T0), the prostate 1
(D1-A), 3 (D3-A), and 8 d (D8-A) after castration and after 1 (D1A), 3
(D3A), and 8 d (D8A) of androgen administration to animals with
involuted prostates. White bars, basal cells; black bars, luminal cells.

TRI and II expression increases
following castration

Because TGF- signaling along prostatic ducts is differentially
regulated by androgens, we determined if the expression of receptors for this cytokine, TRI and II, were also modulated by
androgens. In rats, TGF- and TRI and II mRNA and protein
increased in the prostate after androgen reduction as a result of
castration (Kyprianou and Isaacs, 1989; Kim et al., 1996).
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(distal) higher than the levels observed in the androgen-replete
prostate (Fig. 4, A and B). Similar results were observed with
TRII (unpublished data). Thus, TGF- receptor expression is
diminished by androgens both proximally and distally. The increase in receptor expression in the distal region after castration
may result in an increase in sensitivity to TGF-, leading to
apoptosis and the involution of this region of the gland.
TGF- inhibits proximal cell proliferation,
whereas SCF, EGF, and FGF-2 abrogate
this effect

Figure 4. TRI expression is regulated by androgens in proximal and
distal cells. TRI was detected using RT-PCR (A) and Western blot (B) in the
intact prostate (T0), the prostate 1 (D1-A), 3 (D3-A), and 8 d (D8-A) after
castration and after 1 (D1A), 3 (D3A), and 8 d (D8A) of androgen
administration to animals with involuted prostates.

However, no data exist that indicate whether TGF- receptor
expression differs between proximal and distal regions.
Prostates were removed from mice at time 0 (intact prostate) and 1, 3, 8, and 14 d after castration. After 14 d of involution, some mice were given androgen and prostates were removed 1, 3, 8, and 14 d later. The proximal and distal regions
were examined by RT-PCR (Fig. 4 A) and Western blot (Fig.
4 B) analysis to determine whether androgen withdrawal affected the expression of TRI and II. TRI mRNA and protein
levels increased both proximally and distally after castration and
continued to increase until day 8, and then leveled off. After 8 d
of involution, receptor mRNA and protein levels in the proximal
region were 1.5-fold (P  0.01) and 10-fold (P  0.01) higher,
respectively, than those of the androgen-replete prostate. Similar
increases in mRNA (1.5-fold; P  0.01) and protein (15-fold;
P  0.001) levels were noted in the distal region at this time
(Fig. 4, A and B). After the administration of androgens, the
levels of receptor mRNA and protein decreased both proximally
and distally, although after 8 d of androgen supplementation,
protein levels of TRI remained four- (proximal) or sevenfold
Figure 5. The inhibitory effect of TGF- on cell growth
is opposed by EGF, FGF-2, and SCF. Cells from the
proximal or distal region were seeded (5  103 cells/
well) on collagen and overlaid with medium containing
TGF- (0.5, 1, or 10 ng/ml; A) and either TGF- alone
(0.5 ng/ml) or TGF- together with either EGF (10 ng/
ml), FGF-2 (10 ng/ml), SCF (100 ng/ml), or IGF-1 (10
ng/ml) (B). Control wells received EGF, FGF-2, SCF,
IGF-1, or none of these factors in the absence of TGF-.
Wells were cultured for 10 d, after which cells were
enumerated. The y axis in A is normalized to cells that
were not treated with TGF-. The histograms of the
proximal and distal cells in B cannot be directly compared with each other because of their differential responses to TGF-. The comparisons should be made
between the control (No GF) and experimental samples within each of the two histograms.
84
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The in vitro proliferation of stem cells from a variety of organs
is enhanced by mitogenic cytokines, such as stem cell factor
(SCF), EGF, insulin-like growth factor 1 (IGF-1), and FGF-2
(Isfort et al., 1997; Mitsunari et al., 1999; Santa-Olalla and Covarrubias, 1999; Fortunel et al., 2000a; Deasy et al., 2002). We
therefore examined the effect of these cytokines on the growth
of cells in vitro that were isolated from the proximal and distal
regions of the ducts.
TGF- inhibited the proliferation of both proximal and
distal cells. Low levels of TGF- (0.5 ng/ml) inhibited the
growth of proximal prostate cells by 24.4% and distal cells by
34.5% (P  0.01). At a concentration of 1.0 ng/ml, TGF- inhibited proximal and distal growth by 57.5 and 85.6% (P 
0.001), whereas 10.0 ng/ml TGF- inhibited proximal and distal growth by 85.6 and 99.3% (P  0.001), respectively (Fig.
5 A). Thus, distal cells were more sensitive to TGF- inhibition than were proximal cells (P  0.01 at all concentrations of
TGF-). We determined whether the inhibitory effect of TGF-
on proximal prostate cells could be negated by SCF, EGF,
FGF-2, FGF-7, or IGF-1, all of which induce proliferation in
several stem cell types (Isfort et al., 1997; Mitsunari et al.,
1999; Santa-Olalla and Covarrubias, 1999; Deasy et al., 2002).
TGF-–mediated inhibition of proximal cells was abrogated by
the simultaneous addition of EGF, FGF-2, or SCF. Growth of
proximal cells in wells receiving EGF (10 ng/ml), FGF-2 (10
ng/ml), or SCF (100 ng/ml) along with TGF- (0.5 ng/ml) was
not significantly different from growth in wells that received
the same mitogens but no TGF- (P  0.1; Fig. 5 B). In contrast, EGF, FGF-2, or SCF only partially reversed the inhibition
of growth caused by administration of TGF- to distal cells
(P  0.01; Fig. 5 B). FGF-7 and IGF-1 did not counteract the
inhibitory effect of TGF- on either proximal or distal cells.

The data also indicate that both proximal and distal cells
are sensitive to the inhibitory effects of TGF- with distal cells
being more sensitive than proximal cells. However, in the
proximal cells, the inhibitory effect can be counteracted by the
addition of mitogenic cytokines, such as EGF, FGF-2, or SCF,
suggesting that homeostasis in the proximal region may be
maintained by a balance between inhibitory and stimulatory
cytokines. The distal region, which does not contain the stem
cell compartment, is less sensitive to cytokine-induced reversal
of TGF- inhibition than the proximal region.
We next determined if TGF- had effects on the growth
of clonal cultures of proximal cells. Proximal cells were seeded
at limiting dilution in collagen gels. The growth of cells in
wells containing a single cell was determined in the absence
and presence of neutralizing antibodies to TGF-. There was
significantly higher duct-forming efficiency by single cells in
wells containing antibodies to TGF- with 72.5  5.9% of
these wells containing ducts compared with 14.5  3.2% of
control wells (P  0.001). In addition, the size of the ducts in
wells treated with antibodies to TGF- was significantly larger
(159.2  12.103 m2) than ducts in control wells (54.3 
5.103 m2; P  0.01). This shows a direct action of TGF- on
single proximal cells and also demonstrates that the production
of endogenous TGF- by proximal cells inhibits their proliferation. We have previously shown that single cells from the
proximal region form ducts that contain both basal and luminal
cells (Tsujimura et al., 2002).
Proximal cells are more resistant to the
differentiation-inducing effects of TGF-
than cells from the remaining regions
of ducts

TGF- has been shown to induce the differentiation of a rat
basal cell line to luminal cells (Danielpour, 1999). Therefore,
we determined the effects of TGF- on the colony composition
of cells isolated from the proximal and remaining ductal regions. As TGF- inhibits cell growth, cells were initially cultured in the absence of TGF- and, once clonal growth was established, TGF- (0.1 ng/ml) was added for the final 48 h of
culture and its effect on the composition of colonies (basal, luminal, and intermediate [cells containing both basal and luminal cytokeratins]) was determined. The addition of TGF- to
colonies arising from proximal cells resulted in a twofold decrease (P  0.001) in the incidence of basal colonies and 2.1-

Figure 6. Proximal cells are more resistant to the differentiating-inducing
effects of TGF- than cells from the remaining regions of ducts. (A) Cells
from the proximal and remaining ductal regions (2,000 cells/collagencoated 8-well chamber slide) were cultured for 5–7 d and TGF- (0.1 ng/ml)
was added for 48 h after which colonies of 100 cells were counted and
examined for evidence of basal and luminal cytokeratins. The data are
plotted as the colony type (basal, luminal, or intermediate) as a percentage of the total number of colonies and are the average of four pooled experiments. *, 1.2-fold, P  0.05 NS; **, 1.8-fold, P  0.0001; ***, 4.7fold, P  0.001. (B) Colonies were examined immunohistochemically using
antibodies to basal or luminal cytokeratins and appropriate Alexa Fluor
594 or 488 secondary fluorescent antibodies to determine those colonies
that were comprised of basal (red), intermediate (both basal and luminal),
or luminal (green) cells. Bars, 50 m.

and 2.5-fold increases in luminal and intermediate colonies,
respectively (P  0.002 and P  0.003; Fig. 6 and Tables I
and II). Colonies arising from cells isolated from the remaining
ductal regions were more sensitive to TGF- as an eightfold
decrease in basal colonies was noted (P  0.0001) concomitant
with a 2.2- and a threefold increase in luminal and intermediate
colonies, respectively (P  0.001 and P  0.02; Fig. 6 and
Tables I and II). Significantly more of the colonies arising from
proximal cells had a basal phenotype (35.9  18.9%) after
TGF- addition than those colonies that grew from cells isolated
from the remaining ductal regions (7.6  7.9%; P  0.001).
Similar significant differences were noted in the incidence of

Table I. Proximal cells are more resistant to the differentiation-inducing effects of TGF- than cells from the remaining regions of ducts
Region

Colony type

Control
mean  SDa

 TGF-
mean  SDa

Proximal

Basal
Luminal
Intermediatea
Basal
Luminal
Intermediatea

71.2  12.6
19.7  10.5
9.3  7.8
61.0  26.0
33.0  25.9
6.1  8.3

35.9  18.9
41.2  15.6
23.1  11.9
7.6  7.9
73.9  14.8
18.6  10.1

Remaining

Fold increase

Fold decrease

p-value

2.0

0.001
0.002
0.003
0.0001
0.001
0.02

2.1
2.5
8.0
2.2
3.0

This table and Table II represent a different statistical analysis of the same data set. The data compare the types of colonies in each region in the presence and
absence of TGF-.
a
Colony type as a percentage of total colonies.

TGF- MAINTAINS DORMANCY OF PROSTATIC STEM CELLS • SALM ET AL.

85

Table II. Proximal cells form more basal colonies and fewer luminal colonies than cells from the remaining regions of ducts after TGF- addition
Colony type

Prox  TGF-
mean  SDa

Rem  TGF-
mean  SDa

Basal
Luminal
Intermediateb

35.9  18.9
41.2  15.6
23.1  11.9

7.6  7.9
73.9  14.8
18.6  10.1

Fold increase

Fold decrease

p-value

4.7

0.001
0.0001
NS

1.8
1.2

This table and Table I represent a different statistical analysis of the same data set. The data compare the incidence of basal, luminal, and intermediate colonies from
each region in the presence of TGF-.
a
Colony type as a percentage of total colonies.
b
Intermediate colonies contained cells that expressed both basal and luminal cytokeratins.

luminal colonies after TGF- treatment with cells isolated
from the remaining ductal regions having 1.8-fold more luminal colonies than proximal cells (P  0.0001; Fig. 6 and Tables I and II). These data show that TGF- induces differentiation of basal cells to luminal cells and that cells isolated from
the proximal region are more resistant to the differentiationinducing effects of TGF- than cells from the remaining regions of ducts.
Proximal cells express high levels
of Bcl-2

The proximal region of an intact prostate has high levels of
TGF- signaling, and proximal cells produce and activate significantly more TGF- than distal cells. As high levels of TGF-
have been shown to result in apoptosis after androgen ablation
(Kyprianou and Isaacs, 1989), we examined the mechanism
whereby proximal stem cells could maintain quiescence in the
presence of high levels of TGF- signaling, whereas distal
cells underwent apoptosis under similar conditions. As Bcl-2
prevents apoptosis of hematopoietic stem cells (Domen and
Weissman, 2000) and as the overexpression of Bcl-2 has been
shown to increase the number of these stem cells (Domen et al.,
2000), we examined the expression of Bcl-2 in cells from different regions of prostatic ducts in androgen-replete animals by
FACS analysis.
More Bcl-2–expressing cells were found in the proximal region (42.1  6.9%) than in the remaining regions of
the prostate (27.5  8.2%; P  0.0001; Fig. 7 A). Proximal
cells also expressed 2.2-fold more Bcl-2 per cell than cells
from the remaining regions (P  0.0001) as evidenced by an
increase in the mean fluorescence intensity (MFI) of these
cells (Fig. 7 B). A representative histogram (Fig. 7 C) shows
the increase in both intensity of Bcl-2 expression (MFI) and
the numbers of cells expressing this antigen in the proximal
region (MFI  599; Bcl-2–expressing cells 36%) compared with the cells in the remaining regions (MFI  157,
Bcl-2–expressing cells  18%). Furthermore, examination
of cells expressing high levels of Bcl-2 (cells with a MFI
800) indicates that the cells from the proximal region contain 7.1-fold more Bcl-2high cells than those in the remaining
regions (7.2  2.7 and 1.0  1.0%, respectively; P 
0.00001; Fig. 7 D). Thus, cells with the highest Bcl-2 levels
are almost exclusively located in the proximal region. The
high levels of Bcl-2 in this region may protect proximal cells
from the apoptotic events initiated during involution of the
gland after androgen deprivation.
86

JCB • VOLUME 170 • NUMBER 1 • 2005

Discussion
The regulation of stem cell production within an organ is necessary to maintain homeostasis. The mechanism by which this
occurs in most organs and the alterations that result in pathological conditions are currently unknown. We have previously
shown that prostatic stem cells are concentrated in the proximal
region of prostatic ducts (Tsujimura et al., 2002). We now
show for the first time that there are regional differences in
TGF- activation and signaling consistent with the proximal
location of quiescent prostatic stem cells. Cells from the proximal region of the ducts produce and activate significantly more
TGF- than cells from the distal region but are less sensitive to
its inhibitory effects. We also show that TGF- signaling in
various ductal regions is differentially regulated by androgens
in a manner that indicates that TGF- signaling regulates prostatic homeostasis. In androgen-replete animals, TGF- signaling and Bcl-2 expression are significantly higher in the proxi-

Figure 7. Bcl-2 is highly expressed by cells from the proximal region of
prostatic ducts. (A) More cells in the proximal region of prostatic ducts express Bcl-2 than those from the remaining regions of ducts (P  0.00001).
(B) Cells in the proximal region express higher levels of Bcl-2 per cell, as is
indicated by a higher mean fluorescence intensity (MFI) (P  0.00001).
(C) A representative histogram of Bcl-2 expression by cells from the proximal region (thick solid line; MFI  599) and the remaining ductal regions
(gray filled area; MFI  157). The marker M1 is set such that 1% of control cells are included within this marker. The marker M2 delineates Bcl2high cells with MFI  800. (D) Cells expressing high levels of Bcl-2 (MFI 
800) are 7.1-fold enriched in the proximal region of ducts compared with
those in the remaining ductal regions (P  0.00001).

mal compared with the distal region. The combination of high
TGF- signaling and high Bcl-2 expression promotes quiescence of cells in the proximal region while protecting them
from TGF-–mediated apoptosis. These findings indicate that
TGF- maintains the dormancy of stem cells in the proximal
region of prostatic ducts. During castration-induced involution,
TGF- signaling increases distally and decreases proximally.
In addition, we have found that several growth factors counteract the inhibitory effects of TGF- on proximal cells. TGF-
also promotes the differentiation of basal to luminal cells, and
proximal basal cells are more resistant to the differentiation-inducing effects of TGF- than distal basal cells. Stem cell homeostasis in the proximal region may be maintained by an androgen-controlled balance between levels of the inhibitory
cytokine, TGF-, and mitogenic cytokines, such as EGF,
FGF-2, and SCF.
Our data indicating that stem cells in the proximal region
of androgen-replete animals are maintained in a quiescent state
by high levels of TGF- are strongly supported by the finding
that loss of sensitivity to TGF- in the proximal region of the
ventral prostate, due to expression of a dominant-negative
TGF- receptor, results in the accumulation of multiple layers
of epithelial cells in this region (Kundu et al., 2000). The proximal region of the prostate is enveloped with a thick band of
smooth muscle (Nemeth and Lee, 1996) that produces high levels of TGF- (Nemeth et al., 1997). The abnormal growth in
this region after TGF- abrogation indicates that TGF- plays
an important role in regulating the growth of the proximal region of prostatic ducts.
Previous work has indicated that TGF- inhibits the proliferation of prostatic epithelial cells (Kyprianou and Isaacs,
1989). Androgen reduction as a result of castration increases
the expression of this cytokine and its receptors, and activates
its signaling pathway leading to apoptosis and involution of the
gland (Kyprianou and Isaacs, 1988, 1989; Wikstrom et al.,
1999). After androgen ablation we show that the increases in
TGF- signaling in the distal region correspond with similar
increases in the expression of TRI and II. Increased expression of TRs is likely to sensitize the cells to TGF-, contributing to the enhanced TGF-–mediated pSMAD signals that result in the castration-induced apoptosis of the distal region.
With the replacement of androgens, we show that TRI and II
expression diminishes, thereby facilitating cell growth in the
distal region in response to positive proliferative signals, allowing the prostate to regenerate. Proliferating cells have been
shown to be preferentially located in the distal region of prostatic ducts (Sugimura et al., 1986a,b; Cunha and Donjacour,
1987; Tsujimura et al., 2002). The TRI and II levels decrease
to a level higher than that of intact animals, an unexplained
phenomenon reported previously in rats (Kim et al., 1996). In
the proximal region, whereas TGF- signaling decreases in the
involuting prostate, TRI and II expression increases. In the regenerating prostate, TGF- signaling increases but TRI and II
expression decreases. This suggests that there is a negative
feedback between signaling and receptor expression. We propose that the increase in TR expression in the involuting
proximal prostate sensitizes the cells in this region to TGF-.

Figure 8. A model for the regional regulation of prostatic homeostasis.
A schematic diagram showing that in an androgen-replete prostate high
levels of active TGF- and TGF-–mediated signaling in the proximal stem
cell niche maintain the quiescence of stem cells in this region. In the distal
region, low levels of active TGF- and TGF-–mediated signaling permit
the division of transit-amplifying (TA) cells in this region. After castration,
the decrease in androgen levels with concurrent increased levels of TGF-
and TGF-–mediated signaling distally, lead to apoptosis of cells in this region, with the resulting involution of the prostate gland. Simultaneously,
the decrease in TGF-–mediated signaling in the proximal region sensitizes the cells in this region to mitogenic signals. When androgens are readministered these cells respond to androgen-induced mitogenic cytokines
(GFs), thus contributing to prostatic regeneration. Simultaneously, as the
distal TGF- signaling activity declines, the transit-amplifying cells in this
region also divide, resulting in regeneration of the gland.

The increased sensitivity of this region to TGF- may therefore
restore quiescence once androgens are administered.
Increased levels of TGF- after castration result in apoptosis and involution of the gland (Kyprianou and Isaacs, 1989). It is
therefore of significance that we find that the expression of
Bcl-2, an antiapoptotic protein (Adams and Cory, 1998), is considerably higher in proximal cells than in cells from other regions
of the prostate. These results suggest that high local levels of
Bcl-2 protect the cells in the proximal region from the apoptotic
effects of high levels of TGF-. This region is least affected by
castration and remains mostly intact after involution (Sugimura
et al., 1986a; Rouleau et al., 1990). Of relevance to our findings
is the observation that the apoptotic effects of TGF- are antagonized by Bcl-2 in prostate cancer cells (Bruckheimer and Kyprianou, 2002), indicating that prostate stem and cancer cells both
express high levels of Bcl-2. In addition, Bcl-2 both prevents
apoptosis of hematopoietic stem cells and increases their numbers in vivo (Domen et al., 2000; Domen and Weissman, 2000),
and it is also highly expressed in keratinocyte populations that
are enriched in stem cells (Tiberio et al., 2002). Thus, the expression of high levels of Bcl-2 by prostatic stem cells protects them
from the apoptotic events that regulate the growth, differentiation, and involution of the post–stem cell compartment.
A model for the regional regulation of
prostatic homeostasis

These data are the first to show that TGF- signaling in vivo is
regulated by androgens in a differential manner along the proximal-distal prostatic ductal axis and that the inhibitory effects
of TGF- on proximal cells can be negated by several cytokines. We propose a model (Fig. 8) in which the stem cells, concentrated in the proximal niche, are maintained in a dormant
state in the androgen-replete prostate by high levels of active
TGF- that are produced by the cells in this region. Lower levels of active TGF- distally allow proliferation and differentiation of distal cells, thus accounting for the preferential location
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of dividing cells in this region (Sugimura et al., 1986a,b; Cunha
and Donjacour, 1987; Tsujimura et al., 2002). Stem cells in the
proximal region are protected from apoptosis by high Bcl-2 expression. After castration, the decrease in androgen levels with
concurrent increased levels of TGF- (Kyprianou and Isaacs,
1989) and TGF- signaling distally lead to apoptosis of cells in
this region, with the resulting involution of the prostate gland.
Simultaneously, the decrease in TGF- signaling (less pSMAD
expression) in the proximal region may sensitize these cells to
mitogenic signals. When androgens are readministered these
sensitized cells respond to androgen-induced mitogenic cytokines, thus contributing to prostatic regeneration. As the distal
TGF- signaling activity declines in response to androgens, the
transit-amplifying cells in this region, which are still capable of
proliferation, also divide, resulting in regeneration of the gland.
Our findings that TGF- signaling is differentially regulated by androgens along the proximal-distal ductal axis and that
cells with high Bcl-2 expression are located proximally explains
how the proximal region is preserved largely intact after castration whereas the distal region involutes. It is of interest that Bcl-2
expression is increased in both BPH (Kyprianou et al., 1996)
and prostate cancer (Bruckheimer and Kyprianou, 2002). Our
results may therefore be important in understanding the etiology
of prostatic diseases that result in aberrant proliferation of the
stem cell compartment. For example, the age-related reduction
in androgen levels (van den Beld et al., 2000) may result in less
TGF-–mediated inhibitory signaling in the stem cell compartment. This in turn may sensitize these cells to stimulatory signals resulting in excessive proliferation of stem cells, thus promoting the development of proliferative prostatic diseases.

Materials and methods
Animals
C57Bl/6 mice were housed in a climate-controlled facility and all animal
care and procedures were performed in compliance with the New York
University School of Medicine Institutional Review Board requirements.
Cell isolation and growth in vitro
Cells from the proximal and distal regions of the prostatic ducts of the ventral and dorsal lobes were isolated as described previously (Tsujimura et
al., 2002) and cultured on 96-well collagen-coated plates. The culture medium was DME (Sigma-Aldrich) with 1% FCS (Atlanta Biologicals), and
contained 10 g/ml transferrin, 0.5 g/ml hydrocortisone, 10 ng/ml
cholera toxin, 10 7 M dihydrotestosterone, and 0.1 mM phosphoethanolamine (all from Sigma-Aldrich). Growth factors and antibodies were
added to the culture medium 3 h after cells were seeded and included
100 ng/ml SCF (R&D Systems), 10 ng/ml EGF (Genzyme), 10 ng/ml
FGF-2 (Scios Nova), 10 ng/ml FGF-7 (Scios Nova), 10 ng/ml IGF-1
(Sigma-Aldrich), or 0, 0.5, 1.0, or 10.0 ng/ml TGF- (R&D Systems). Cytokines and antibodies were added alone or in combination with each
other, as indicated in Results. Control wells received either no factors or all
the factors. The medium was removed and replaced with fresh medium
and additives every 2 d. Cell growth in each assay was measured and
quantified as described previously (Tsujimura et al., 2002). Experiments
were performed in triplicate.
Clonal cultures from single proximal cells were obtained by seeding
cells at limiting dilution in collagen gels in 96-well dishes. Each well was
examined for evidence of single cells and the incidence of colony/duct
formation and the sizes of the ducts (NIH image analysis program, http://
rsb.info.nih.gov/nih-image) were determined in the absence and presence of a neutralizing antibody to TGF- (20 g/ml; antibody 1D11.16;
R&D Systems), which neutralizes TGF-1, 2, and 3. Fresh medium–containing antibodies was added at 48-h intervals and the incidence and
sizes of ducts was determined after 14 d.
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The effects of TGF- on the colony composition of cells isolated
from the proximal and remaining ductal regions was done by seeding
2,000 cells from each region on collagen-coated 8-well chamber slides
(Tsujimura et al., 2002) to determine if colonies obtained from cells isolated from these regions of ducts demonstrated differential sensitivity to
TGF-. As TGF- inhibits cell growth, cells were cultured in the absence of
TGF- for 5–7 d, and once clonal growth was established, 0.1 ng/ml TGF-
was added for the final 48 h of culture in DME containing 10% FCS, and
its effect on the composition of colonies of 100 cells (basal, luminal, and
intermediate [cells containing both basal and luminal cytokeratins]) was
determined. This experiment was performed four times seeding triplicate
wells for each condition in each experiment.
Immunohistochemistry
Tissue sections were deparaffinized in xylene, followed by washing in ethanol and rehydration in PBS. Endogenous peroxidase activity was blocked
with 0.5% hydrogen peroxide in PBS for 30 min at RT. Sections were incubated for 30 min at 37 C in hyaluronidase (1 mg/ml in 0.1 M sodium acetate, pH 5.5). Slides were rinsed briefly and were incubated for 1 h at RT
with 5% normal goat serum in TBS containing 1% BSA. pSMAD2/3 was
detected by incubating sections with a polyclonal rabbit anti-pSMAD2/3
antibody (10 g/ml; Santa Cruz Biotechnology, Inc.) for 24 h at 4 C.
Slides were washed, and the secondary antibody (goat anti–rabbit HRP;
R&D Systems) was added for 1 h at RT. Slides were washed and the Nova
red substrate kit (Vector Laboratories) was used to detect HRP activity. At
least 200 nuclei were counted for each time point in duplicate slides from
each of two animals. Basal and luminal cells were scored based on their location within ducts. Experiments were performed in triplicate. Basal and luminal cytokeratins in colonies cultured from different regions of ducts were
visualized using antibodies to CK 5 (Babco/Covance) and CK 8 (RDI) and
appropriate Alexa Flour 594 or 488 secondary fluorescent antibodies
(Molecular Probes). Slides were mounted using Fluoromount G (Southern
Biotechnology Associates, Inc.). Fluorescent images were captured using
a fluorescent microscope (model Axioskop 2; Carl Zeiss MicroImaging,
Inc.) using lens 20/0.50 with a digital camera (model CA742-95;
Hamamatsu) using Openlab 2.2.5 software. Light microscopic images
were captured using a DMLD light microscope (Leica) using lens 20/
0.40 with a digital camera (model 3.2.0; Diagnostic Instruments) using
Spot software. Image processing was done using Adobe Photoshop.
TGF- production
Production of TGF- was determined by a TGF- bioassay, which uses TGF–responsive mink lung cells (TMLC; Abe et al., 1994; Salm et al., 2000b)
and measures luciferase activity produced by these cells as a consequence
of TGF- activation. Proximal and distal cells were seeded at 4  104 cells/
ml in 24-well dishes in the culture medium described in Tsujimura et al.
(2002), which was replaced by 2 ml of 0.1% BSA in DME after 24 h. Both
total and active TGF- secreted into the 0.1% BSA medium were quantified.
Total TGF- production was measured after converting latent TGF- in the
medium to its active form by heat activation at 80 C. A neutralizing antibody to TGF- (20 g/ml; antibody 1D11.16; R&D Systems), which neutralizes TGF-1, 2, and 3, was added to triplicate samples of conditioned
medium to confirm that the luciferase activity measured in the assay was
generated by TGF-. All experiments were performed in triplicate.
TGF- activation in a coculture assay
TGF- activation was measured using a coculture assay that combined either the proximal or the distal cells with TGF-–responsive mink lung cells
(Abe et al., 1994; Salm et al., 2000b). Coculture of the prostate cells with
TMLC increases the sensitivity of the TGF- assay by allowing any active
TGF- to be captured immediately by the indicator cells and thus measures
directly the amount of active TGF- generated by the prostate cells. Proximal or distal cells (4  103 cells/well) were coseeded with TMLC (5 
103 cells/well) in primary culture medium in a 96-well plate. Neutralizing
antibodies to TGF- were added to control wells to confirm that the luciferase activity measured in the assay was generated by TGF-. Active
TGF- was measured as described previously (Abe et al., 1994; Salm et
al., 2000b). Experiments were performed in triplicate.
RT-PCR
Semi-quantitative RT-PCR was used to examine expression of message for
TGF- receptors I and II (TRI and TRII). Mice were castrated to initiate
prostate involution by androgen withdrawal. Two mice were killed and
their prostates removed at each of the following time points: day 0 (intact
T0 control) and days 1, 3, 8, and 14 after castration. Castrated mice with
involuted prostates were given testosterone subcutaneously (slow-release

subcutaneous androgen pellet; Innovative Research). Two mice were killed
and their prostates removed at each of the following time points: days 1,
3, 8, and 14 after androgen supplementation. In all cases, the proximal
and distal regions were dissected from both the ventral and the dorsal
prostates in collagenase as previously described (Tsujimura et al., 2002).
Total RNA was extracted using TriZol (Invitrogen). 1 g of total RNA was
amplified for the required products using the Titan One Tube RT-PCR System kit (Roche). Primers used were as follows: -actin forward, GAC GTC
ATG AAG ACT TGC TG; -actin reverse, ACA GCA GCA AAG CCT GTT
GG; TRI forward, TTG CTG GAC CAG TGT GCT TCG; TRI reverse,
CCA TCT GTT TGG GAT ATT TGG CC; TRII forward, AGC AGA AGC
TGA GTT CAA CCT GGG; TRII reverse, GGA GCC ATG TAT CTT GCA
GTT CCC. Amplification conditions were as follows: 42 C for 55 min;
94 C for 2 min (1 cycle); 94 C for 1 min; 55 C for 1 min; 72 C for 1
min (25 cycles); 72 C for 10 min (1 cycle). Products were resolved on
a 1% agarose gel in Tris acetate buffer and photographed. Images were
scanned, and the average pixel intensity for each band was measured using UN-SCAN-IT software (Silk Scientific Software). Experiments were performed in triplicate.
Western blot analysis
The expression of TRI and II proteins was examined by Western blot
analysis. Prostate cells were prepared as described for the RT-PCR experiments. Protein was extracted in lysis buffer (Salm et al., 2000a), quantified using a BCA kit (Pierce Chemical Co.), and equal amounts of protein
were loaded on 8 or 10% reducing SDS-PAGE. Gels were electroblotted
onto a polyvinylidene difluoride membrane (Immobilon-P; Millipore) with
transfer buffer containing 10% (vol/vol) methanol. Blots were incubated
for 1 h at RT with appropriate primary antibodies. HRP-labeled secondary
antibodies were added for 1 h at RT. Bands were visualized by ECL (Amersham Biosciences). Western blot films were scanned and the average
pixel intensity for each band was measured using UN-SCAN-IT software.
Experiments were performed in triplicate.
Cell preparation for FACS analysis
Cells were isolated from the proximal region of prostatic ducts (adjacent to
the urethra) and from the remainder of the prostate (includes the distal and
intermediate regions of ducts; Tsujimura et al., 2002). The cells from these
two regions were dissociated by incubation with 0.5% collagenase Type II
(Sigma-Aldrich) in HBSS plus 7.5% FCS for 45 min at 37 C, followed by
digestion in 0.25% trypsin for 8 min at 37 C. Cells were washed and resuspended in PBS, fixed in PFA, and permeabilized with Tween 20. Cells
were resuspended in PBS supplemented with BSA (0.1%), sodium azide
(0.01%), and aprotinin (20 g/ml; FACS buffer). Fc receptors were
blocked with mouse CD16/32 antibodies (Caltag Laboratories) for 10 min
on ice, and cells were subsequently incubated with 20 g/ml anti–Bcl-2–PE
(Santa Cruz Biotechnology, Inc.) or control IgG1-PE (DakoCytomation) for
30 min on ice and washed twice with FACS buffer. Cells were analyzed
on a FACSCalibur flow cytometer (Becton Dickinson) and the data were
analyzed using CellQuest software (Becton Dickinson).
Statistical analysis
The results are depicted as the means  SD of each set of data. Comparisons between groups were made using the 2-tailed, paired t test, or in the
case of different sized samples, the Mann Whitney U test. A p-value of
0.05 is considered statistically significant.
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